Results 141 to 150 of about 7,531 (200)

Innovative adjuvant strategies for next-generation pertussis vaccines. [PDF]

Hum Vaccin Immunother
Yu G, Yang W, Ma Y, Zhang N, Tang D, Jin Y, Shi L, Wang M, Liu D, Xue C, Sun B.   +10 more
europepmc   +1 more source

Recommendations for Influenza Vaccination in Immunocompromised Patients. [PDF]

Infect Chemother
Song JY, Kwon KT, Park WB, Noh JY, Park SH, Choo EJ, Choi MJ, Choi JY, Heo JY, Choi WS, Committee of Adult Immunization in the Korean Society of Infectious Diseases.   +10 more
europepmc   +1 more source

Effect of Different Adjuvants on the Immunogenicity of a Recombinant Herpes Zoster Vaccine in Mice, Rats and Non-Human Primates. [PDF]

Vaccines (Basel)
Liu X, Gong S, Xu J, Wei Y, Chen X, Wu Y, Zhang Z, Ma J, Yang Y, Tan S.   +9 more
europepmc   +1 more source

Next-generation Candida albicans vaccine VXV-01 containing recombinant Als3p and Hyr1p antigens for invasive Candida infections. [PDF]

Sci Rep
Singh S, Youssef EG, Barbarino A, Hautau H, Nabeela S, Gebremariam T, Alkhazraji S, Ostroff G, Christensen D, Cochrane T, Ibrahim AS.   +10 more
europepmc   +1 more source

PIN15 COST EFFECTIVENESS OF MF59 ADJUVANTED INFLUENZA VACCINE IN FRANCE

Value in Health, 2007
Chambers, J, Eijgelshoven, I, Piercy, J, Wait, S   +3 more
openaire   +1 more source

A novel adjuvant system BK-02 with CpG2006 and MF59 enhances the immunogenicity of a herpes zoster subunit vaccine. [PDF]

Front Immunol
Wang Z, Guo Y, Tang X, Sun Y, Wu T, Peng H, Wang C, Su W, Jiang C, Zang Y, Quan Y, Xu K, Sun B.   +12 more
europepmc   +1 more source

Developing a Vaccine Against Human Cytomegalovirus: Identifying and Targeting HCMV's Immunological Achilles' Heel. [PDF]

Vaccines (Basel)
Lankina A, Raposo M, Hargreaves A, Atkinson C, Griffiths P, Reeves MB.   +5 more
europepmc   +1 more source

Nanoparticle vaccine based on the pre-fusion F glycoprotein of respiratory syncytial virus elicits robust protective immune responses. [PDF]

J Virol
Hu Z, Tian S, Zhou Y, Wang Y, Li Y, Zhang S, Wei P, Zhuang Z, Ren L, Liu J, Zang N, Yu R, Ding Y, Guo Y, Jing C, Chen H, Zhang C, Yao Y, Deng C, Wei R, Zhou P, Zou Y, Zhao D, Liu S, Fu M, Mo X, Peng G, Liu E, Zhao J, Li Y, Jin J.   +30 more
europepmc   +1 more source

Nano/Micro-Enabled Modification and Innovation of Conventional Adjuvants for Next-Generation Vaccines. [PDF]

J Funct Biomater
Liu X, Yang X, Tao L, Li X, Chen G, Liu Q.   +5 more
europepmc   +1 more source

Correction to "Relative Efficacy, Effectiveness and Safety of Newer And/Or Enhanced Seasonal Influenza Vaccines for the Prevention of Laboratory-Confirmed Influenza in Individuals Aged 18 Years and Over: Update of a Systematic Review". [PDF]

Rev Med Virol
europepmc   +1 more source